S&P 500   3,298.75 (+0.13%)
DOW   26,770.30 (+0.40%)
QQQ   269.15 (-0.09%)
AAPL   437.59 (+0.42%)
MSFT   211.65 (-2.26%)
FB   248.91 (-1.21%)
GOOGL   1,470.70 (-0.81%)
AMZN   3,122.62 (+0.34%)
NVDA   447.13 (+1.53%)
CGC   19.29 (+1.21%)
BABA   261.91 (+1.54%)
TSLA   1,474.40 (-0.71%)
MU   51.13 (+1.47%)
GE   6.15 (+0.65%)
AMD   85.02 (+9.46%)
T   30.00 (+1.28%)
F   6.86 (+2.54%)
ACB   10.81 (+3.74%)
GILD   70.75 (-1.37%)
NFLX   508.07 (+1.90%)
DIS   117.39 (+0.89%)
BAC   24.95 (-0.16%)
BA   164.84 (+1.58%)
S&P 500   3,298.75 (+0.13%)
DOW   26,770.30 (+0.40%)
QQQ   269.15 (-0.09%)
AAPL   437.59 (+0.42%)
MSFT   211.65 (-2.26%)
FB   248.91 (-1.21%)
GOOGL   1,470.70 (-0.81%)
AMZN   3,122.62 (+0.34%)
NVDA   447.13 (+1.53%)
CGC   19.29 (+1.21%)
BABA   261.91 (+1.54%)
TSLA   1,474.40 (-0.71%)
MU   51.13 (+1.47%)
GE   6.15 (+0.65%)
AMD   85.02 (+9.46%)
T   30.00 (+1.28%)
F   6.86 (+2.54%)
ACB   10.81 (+3.74%)
GILD   70.75 (-1.37%)
NFLX   508.07 (+1.90%)
DIS   117.39 (+0.89%)
BAC   24.95 (-0.16%)
BA   164.84 (+1.58%)
S&P 500   3,298.75 (+0.13%)
DOW   26,770.30 (+0.40%)
QQQ   269.15 (-0.09%)
AAPL   437.59 (+0.42%)
MSFT   211.65 (-2.26%)
FB   248.91 (-1.21%)
GOOGL   1,470.70 (-0.81%)
AMZN   3,122.62 (+0.34%)
NVDA   447.13 (+1.53%)
CGC   19.29 (+1.21%)
BABA   261.91 (+1.54%)
TSLA   1,474.40 (-0.71%)
MU   51.13 (+1.47%)
GE   6.15 (+0.65%)
AMD   85.02 (+9.46%)
T   30.00 (+1.28%)
F   6.86 (+2.54%)
ACB   10.81 (+3.74%)
GILD   70.75 (-1.37%)
NFLX   508.07 (+1.90%)
DIS   117.39 (+0.89%)
BAC   24.95 (-0.16%)
BA   164.84 (+1.58%)
S&P 500   3,298.75 (+0.13%)
DOW   26,770.30 (+0.40%)
QQQ   269.15 (-0.09%)
AAPL   437.59 (+0.42%)
MSFT   211.65 (-2.26%)
FB   248.91 (-1.21%)
GOOGL   1,470.70 (-0.81%)
AMZN   3,122.62 (+0.34%)
NVDA   447.13 (+1.53%)
CGC   19.29 (+1.21%)
BABA   261.91 (+1.54%)
TSLA   1,474.40 (-0.71%)
MU   51.13 (+1.47%)
GE   6.15 (+0.65%)
AMD   85.02 (+9.46%)
T   30.00 (+1.28%)
F   6.86 (+2.54%)
ACB   10.81 (+3.74%)
GILD   70.75 (-1.37%)
NFLX   508.07 (+1.90%)
DIS   117.39 (+0.89%)
BAC   24.95 (-0.16%)
BA   164.84 (+1.58%)
Log in

NYSE:APHAAphria Stock Price, Forecast & News

$4.96
+0.05 (+1.02 %)
(As of 08/4/2020 03:45 PM ET)
Add
Compare
Today's Range
$4.79
Now: $4.96
$4.96
50-Day Range
$4.07
MA: $4.63
$6.00
52-Week Range
$1.95
Now: $4.96
$7.60
Volume508,644 shs
Average Volume6.74 million shs
Market Capitalization$1.43 billion
P/E Ratio55.11
Dividend YieldN/A
Beta2.19
Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc. is headquartered in Leamington, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 4.4Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.57 out of 5 stars


Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$179.29 million
Book Value$5.23 per share

Profitability

Net Income$-12,480,000.00

Miscellaneous

Employees300
Market Cap$1.43 billion
Next Earnings Date10/20/2020 (Estimated)
OptionableNot Optionable
$4.96
+0.05 (+1.02 %)
(As of 08/4/2020 03:45 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive APHA News and Ratings via Email

Sign-up to receive the latest news and ratings for APHA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Aphria (NYSE:APHA) Frequently Asked Questions

How has Aphria's stock been impacted by COVID-19 (Coronavirus)?

Aphria's stock was trading at $2.70 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, APHA shares have increased by 83.7% and is now trading at $4.96.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Aphria?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Aphria
.

When is Aphria's next earnings date?

Aphria is scheduled to release its next quarterly earnings announcement on Tuesday, October 20th 2020.
View our earnings forecast for Aphria
.

How were Aphria's earnings last quarter?

Aphria Inc (NYSE:APHA) issued its quarterly earnings data on Tuesday, April, 14th. The company reported $0.02 earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.04) by $0.06. The firm had revenue of $144.40 million for the quarter, compared to the consensus estimate of $130.74 million. Aphria had a net margin of 5.75% and a negative return on equity of 0.30%. The business's revenue for the quarter was up 96.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.20) earnings per share.
View Aphria's earnings history
.

What price target have analysts set for APHA?

8 brokerages have issued 12 month target prices for Aphria's stock. Their forecasts range from $7.00 to $11.00. On average, they anticipate Aphria's stock price to reach $8.83 in the next twelve months. This suggests a possible upside of 78.0% from the stock's current price.
View analysts' price targets for Aphria
.

Has Aphria been receiving favorable news coverage?

News headlines about APHA stock have been trending very negative recently, according to InfoTrie. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Aphria earned a media sentiment score of -3.6 on InfoTrie's scale. They also gave news articles about the company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an effect on the company's share price in the near term.
View the latest news about Aphria
.

Who are some of Aphria's key competitors?

What other stocks do shareholders of Aphria own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Tilray (TLRY), NVIDIA (NVDA), Alibaba Group (BABA), OrganiGram (OGI), Advanced Micro Devices (AMD), HEXO (HEXO) and Charlotte's Web (CWBHF).

Who are Aphria's key executives?

Aphria's management team includes the following people:
  • Mr. Carl A. Merton, Chief Financial Officer
  • Ms. Megan McCrae, Director of Marketing
  • Mr. Irwin D. Simon, Interim CEO & Chairman
  • Mr. Jakob Ripshtein, Pres
  • Mr. Gary Leong, Chief Science Officer (Age 54)

What is Aphria's stock symbol?

Aphria trades on the New York Stock Exchange (NYSE) under the ticker symbol "APHA."

Who are Aphria's major shareholders?

Aphria's stock is owned by a variety of retail and institutional investors. Top institutional investors include Intact Investment Management Inc. (0.38%), AdvisorShares Investments LLC (0.20%), CIBC Asset Management Inc (0.06%), Actinver Wealth Management Inc. (0.04%), Hilton Capital Management LLC (0.04%) and Cambridge Investment Research Advisors Inc. (0.02%).

Which institutional investors are selling Aphria stock?

APHA stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, and Actinver Wealth Management Inc..

Which institutional investors are buying Aphria stock?

APHA stock was purchased by a variety of institutional investors in the last quarter, including Intact Investment Management Inc., AdvisorShares Investments LLC, Hilton Capital Management LLC, Eastern Bank, Cambridge Investment Research Advisors Inc., Zurcher Kantonalbank Zurich Cantonalbank , CIBC Asset Management Inc, and Cahaba Wealth Management Inc..

How do I buy shares of Aphria?

Shares of APHA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aphria's stock price today?

One share of APHA stock can currently be purchased for approximately $4.96.

How big of a company is Aphria?

Aphria has a market capitalization of $1.43 billion and generates $179.29 million in revenue each year. The company earns $-12,480,000.00 in net income (profit) each year or ($0.11) on an earnings per share basis. Aphria employs 300 workers across the globe.

What is Aphria's official website?

The official website for Aphria is aphriainc.com.

How can I contact Aphria?

Aphria's mailing address is 245 TALBOT STREET W., LEAMINGTON A6, N8H 1N8.

This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.